These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8059012)

  • 1. Naloxone enhances angiotensin II-induced increase in serum luteinizing hormone concentrations in normal women.
    Coiro V; Cigarini C; Volpi R; Capretti L; Bacchi-Modena A; Chiodera P
    Regul Pept; 1994 May; 51(2):161-7. PubMed ID: 8059012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced frequency of pulsatile luteinizing hormone secretion in the luteal phase of the rhesus monkey. Involvement of endogenous opiates.
    Van Vugt DA; Lam NY; Ferin M
    Endocrinology; 1984 Sep; 115(3):1095-101. PubMed ID: 6745188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone increases the angiotensin II stimulated rise of arginine vasopressin and oxytocin secretion in man.
    Coiro V; Chiodera P
    Neuroendocrinology; 1991 Mar; 53(3):209-13. PubMed ID: 2041583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endogenous opioid peptides in the initiation of the midcycle luteinizing hormone surge in normal cycling women.
    Rossmanith WG; Mortola JF; Yen SS
    J Clin Endocrinol Metab; 1988 Oct; 67(4):695-700. PubMed ID: 3138276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia.
    Larrea F; Sandoval JL; Salinas E; Franco-Rodriguez VA; Méndez I; Ulloa-Aguirre A
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):591-600. PubMed ID: 8548944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome.
    Berga SL; Yen SS
    Clin Endocrinol (Oxf); 1989 Feb; 30(2):177-84. PubMed ID: 2532984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference in luteinizing hormone response to an opioid antagonist in beef heifers and cows.
    Mahmoud AI; Thompson FN; Peck DD; Mizinga KM; Leshin LS; Rund LA; Stuedemann JA; Kiser TE
    Biol Reprod; 1989 Sep; 41(3):431-7. PubMed ID: 2590714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of naloxone on endogenous opioid regulation of pituitary gonadotropins and prolactin during the menstrual cycle.
    Snowden EU; Khan-Dawood FS; Dawood MY
    J Clin Endocrinol Metab; 1984 Aug; 59(2):298-302. PubMed ID: 6330154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid modulation of LH secretion in the ewe.
    Brooks AN; Lamming GE; Lees PD; Haynes NB
    J Reprod Fertil; 1986 Mar; 76(2):693-708. PubMed ID: 3701707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naloxone-induced prolactin secretion in women: evidence against a direct prolactin stimulatory effect of endogenous opioids.
    Cetel NS; Quigley ME; Yen SS
    J Clin Endocrinol Metab; 1985 Jan; 60(1):191-6. PubMed ID: 3964791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone stimulation of luteinizing hormone secretion in the female monkey: influence of endocrine and experimental conditions.
    Van Vugt DA; Bakst G; Dyrenfurth I; Ferin M
    Endocrinology; 1983 Nov; 113(5):1858-64. PubMed ID: 6414806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased central opioid activity in premenstrual syndrome: luteinizing hormone response to naloxone.
    Rapkin AJ; Shoupe D; Reading A; Daneshgar KK; Goldman L; Bohn Y; Brann DW; Mahesh VB
    J Soc Gynecol Investig; 1996; 3(2):93-8. PubMed ID: 8796815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of opioid blockade and GnRH administration upon luteinizing hormone secretion in patients with anorexia nervosa during the stages of weight loss and weight recovery.
    García-Rubí E; Vazquez-Alemán D; Mendez JP; Salinas JL; Garza-Flores J; Ponce-de-León S; Perez-Palacios G; Ulloa-Aguirre A
    Clin Endocrinol (Oxf); 1992 Dec; 37(6):520-8. PubMed ID: 1286522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal twenty-four hour pattern of pulsatile luteinizing hormone secretion and the response to naloxone in women with hyperprolactinaemic amenorrhoea.
    Tay CC; Glasier AF; Illingworth PJ; Baird DT
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):599-606. PubMed ID: 8252751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women.
    Bondanelli M; Ambrosio MR; Franceschetti P; Guerrini R; Valentini A; degli Uberti EC
    Hum Reprod; 1998 May; 13(5):1159-62. PubMed ID: 9647539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of endotoxin on LH secretion in the ovariectomized monkey are prevented by naloxone but not by an interleukin-1 receptor antagonist.
    Xiao E; Xia-Zhang L; Ferin M
    Neuroimmunomodulation; 2000; 7(1):6-15. PubMed ID: 10601814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sodium valproate on luteinizing hormone secretion in pre- and postmenopausal women and its modulation by naloxone infusion.
    Popovic V; Spremovic-Radjenovic S; Eric-Marinkovic J; Grossman A
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2520-4. PubMed ID: 8675571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulatory effect of angiotensin II upon luteinizing hormone release normal women.
    degli Uberti EC; Trasforini G; Margutti A; Ambrosio MR; Rossi R; Pansini R
    Neuroendocrinology; 1991 Feb; 53(2):204-8. PubMed ID: 1901635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective stimulation of daily LH secretion by the combined treatment with melatonin and naloxone in luteal-phase ewes.
    Misztal T; Romanowicz K
    Acta Neurobiol Exp (Wars); 2005; 65(1):1-9. PubMed ID: 15794026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endogenous opioids in reducing the frequency of pulsatile luteinizing hormone secretion induced by progesterone in normal women.
    Steele PA; Judd SJ
    Clin Endocrinol (Oxf); 1986 Dec; 25(6):669-74. PubMed ID: 3652469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.